June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Effects of pretreatment with the radioprotector ortho-phospho-L-tyrosine (pTyr) on Rb+/- mice after radiation exposure - Implication for the treatment of retinoblastoma patients with radiotherapy
Author Affiliations & Notes
  • Alexander Tschulakow
    Section of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Tuebingen, Germany
  • Stephan Huber
    Laboratory of Experimental Radiooncology, Division of Radiooncology, University of Tuebingen, Tuebingen, Germany
  • Monika Rittgarn
    Section of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Tuebingen, Germany
  • Hans-Peter Rodemann
    Division of Radiobiology & Molecular Environmental Research, Department of Radiation Oncology, University Hospital, Tuebingen, Germany
  • Ulrich Schraermeyer
    Section of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Tuebingen, Germany
    STZ OcuTox, Preclinical Drug Assessment, Hechingen, Germany
  • Sylvie Julien
    Section of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Tuebingen, Germany
    STZ OcuTox, Preclinical Drug Assessment, Hechingen, Germany
  • Footnotes
    Commercial Relationships Alexander Tschulakow, None; Stephan Huber, None; Monika Rittgarn, None; Hans-Peter Rodemann, None; Ulrich Schraermeyer, None; Sylvie Julien, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 72. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alexander Tschulakow, Stephan Huber, Monika Rittgarn, Hans-Peter Rodemann, Ulrich Schraermeyer, Sylvie Julien, ; Effects of pretreatment with the radioprotector ortho-phospho-L-tyrosine (pTyr) on Rb+/- mice after radiation exposure - Implication for the treatment of retinoblastoma patients with radiotherapy. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):72.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Retinoblastoma (Rb) is the most frequent ocular tumor in children and if let untreated, can cause death. Like the most head and neck tumors it is sensitive to radiotherapy (RT). However, the therapy has its risks like damage of healthy tissues recurrence and development of treatment-induced secondary tumors.<br /> The aim of this study is to investigate the ability of the radioprotector pTyr to prevent RT-induced secondary tumors and other side-effects observed after RT.

 
Methods
 

B6;129-Rb1tm3Tyj/J mice having a mutation in one of the Rb -gen allele were used. Although these mice do not develop a Rb, this model was chosen because Rb-patients having a similar mutation have a higher risk of developing secondary tumors induced by RT. One group of mice was treated with intraperitoneal injections of pTyr 16 hours before each irradiation. Another group was only irradiated. Both groups were irradiated over a period of 3 weeks 3 times a week with a dosage of 5 Gy per exposure (Fig.1). All animals were investigated using SLO/OCT and histologically 1, 3, 6 and 9 months after irradiation (Ir) . Radiation-induced tumor induction as well as normal tissue radiation toxicity were evaluated as function of pTyr-treatment.

 
Results
 

The first visible effect of the Ir was the graying of the hair coat in the area of Ir. This effect was reduced in the pTyr treated mice. The results of the OCT- analysis showed that 3 and 6 months after Ir the thickness of the retina of the mice was significantly lower in the untreated group (n=12) compared to the pTyr treated one (n=12) (p<0.05 3 months and p<0.001 6 months after Ir). The histological analysis of the retina showed a significant photoreceptor loss in the untreated group vs. the pTyr treated one (p<0.001 3 months and p<0.0001 6 months after Ir) .

 
Conclusions
 

Our results show, that the application of pTyr before irradiation significantly reduces the negative effects of radiation on the hair coat and retina. The results of the analysis 9 months after Ir, the appearance of secondary tumors as well as the potential benefit of the pretreatment with pTyr are currently under investigation.  

 
fig. 1: (a) linear accelarator Linac-G (Phillips), (b) the mouse fixation units, (c) 6 Rb+/- mice fixed for radiation exposure, (d) scheme of the assembly of the<br /> experiment.
 
fig. 1: (a) linear accelarator Linac-G (Phillips), (b) the mouse fixation units, (c) 6 Rb+/- mice fixed for radiation exposure, (d) scheme of the assembly of the<br /> experiment.

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×